Vitamin B12 Deficiency is NOT Normal
Vitamin B12 deficiency is never considered normal in adults and always requires investigation and treatment, regardless of age, dietary habits, or gastrointestinal history. 1
Understanding What "Normal" Means
The confusion often arises because laboratory reference ranges vary between facilities and may not reflect optimal health. Here's the critical distinction:
- Serum B12 <150 pmol/L (<203 pg/mL) is clearly deficient and requires immediate treatment 1
- Serum B12 180-350 pg/mL falls in an indeterminate zone where functional deficiency may exist despite "normal" lab values 1, 2
- Standard serum B12 testing misses functional deficiency in up to 50% of cases, as demonstrated in the Framingham Study where 12% had low serum B12, but an additional 50% had elevated methylmalonic acid indicating metabolic deficiency despite "normal" serum levels 1
Why B12 Deficiency Occurs (But Is Never Normal)
While certain populations have higher risk, the deficiency itself remains pathological:
High-Risk Populations Requiring Screening 1, 2
- Age >75 years: 18.1% have metabolic deficiency; 25% of those ≥85 years have B12 <170 pmol/L 1
- Gastrointestinal conditions: Atrophic gastritis (affects 20% of older adults), ileal resection >20 cm, Crohn's disease with ileal involvement, post-bariatric surgery 1, 3, 4
- Medication use: Metformin >4 months, PPI or H2 blockers >12 months 1, 5
- Dietary restrictions: Strict vegetarians/vegans who consume no animal products 1, 5
Diagnostic Algorithm When Deficiency Is Suspected
- Order serum total B12 (costs ~£2, rapid turnaround) 1
- Include complete blood count to assess for megaloblastic anemia 1
Step 2: Interpret Results 1, 2
- B12 <180 pg/mL: Confirmed deficiency → initiate treatment immediately 1
- B12 180-350 pg/mL: Indeterminate → proceed to Step 3 1
- B12 >350 pg/mL: Deficiency unlikely, but consider functional markers if high clinical suspicion persists 1
Step 3: Confirm Functional Deficiency (for indeterminate results) 1, 2
- Measure methylmalonic acid (MMA): >271 nmol/L confirms functional B12 deficiency with 98.4% sensitivity 1
- Consider homocysteine: >15 μmol/L supports deficiency (less specific than MMA) 1
- MMA detects an additional 5-10% of patients with B12 deficiency who have low-normal B12 levels 1
Critical Clinical Pitfalls
Never rely solely on serum B12 to rule out deficiency, especially in patients >60 years where metabolic deficiency is common despite normal serum levels 1. The American College of Physicians rates this recommendation as high-strength evidence 1.
Neurological symptoms often present before hematologic changes and can become irreversible if untreated 1. Common manifestations include:
- Cognitive difficulties, memory problems, "brain fog" 1, 2
- Peripheral neuropathy (paresthesias, numbness) 1, 2
- Ataxia, gait disturbances 2
- Glossitis or oral symptoms 1
Never administer folic acid before treating B12 deficiency, as it may mask anemia while allowing irreversible neurological damage to progress 1, 6, 3.
Treatment Approach
Once deficiency is confirmed, treatment is mandatory:
For deficiency WITHOUT neurological involvement 6:
- Hydroxocobalamin 1 mg IM three times weekly for 2 weeks 6
- Then maintenance: 1 mg IM every 2-3 months lifelong 6
For deficiency WITH neurological involvement 6:
- Hydroxocobalamin 1 mg IM on alternate days until no further improvement 6
- Then maintenance: 1 mg IM every 2 months lifelong 6
Oral therapy alternative 1, 5:
- Oral B12 1000-2000 mcg daily is as effective as IM for most patients 1
- Consider IM if severe neurologic manifestations, confirmed malabsorption, or oral therapy fails 1
Special Populations Requiring Lifelong Prophylactic Treatment
Even without documented deficiency, these patients require indefinite supplementation 6, 3:
- Ileal resection >20 cm: 1000 mcg IM monthly for life 6, 3
- Post-bariatric surgery: 1000-2000 mcg/day oral OR 1000 mcg/month IM 6
- Pernicious anemia (confirmed intrinsic factor antibodies): Lifelong IM injections 1
Monitoring After Treatment Initiation
- Recheck at 3 months, then 6 and 12 months in the first year 6
- Annual monitoring thereafter once levels stabilize 6
- Target homocysteine <10 μmol/L for optimal cardiovascular outcomes 1, 6
The bottom line: B12 deficiency represents a pathological state requiring diagnosis and treatment. While certain populations have higher prevalence, the deficiency itself is never "normal" and carries risk of irreversible neurological damage if left untreated.